Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XLPAD-TRACE Trial
NCT02660866Phase 4Unknown
- Sponsor
- VA North Texas Health Care System
- Start
- Jul 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vorapaxar in peripheral artery disease (PAD), intermittent claudication (IC), sponsored by VA North Texas Health Care System. Status: unknown.
02
Drugs
vorapaxar
03
Conditions
peripheral artery disease (PAD)intermittent claudication (IC)
Beyond the preview
Go deeper on NCT02660866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660866.